You are here:
Some of our top research stories from the past year.
People living with schizophrenia will have access to a whole new class of medicine following the US Food and Drug Administration (FDA) approval of the drug ‘Cobenfy’.
Scientists from Monash University has solved the structure of a protein, ‘LYCHOS’, which can detect and regulate cell growth by sensing cholesterol levels in the body.
The clinical-stage biopharmaceutical company, Seaport Therapeutics has announced the closing of an oversubscribed US$225 million Series B financing round.
Researchers developed the first ever quantitative systems pharmacology model to describe and predict meropenem resistance across seven strains of the bacterium Pseudomonas aeruginosa.
Australian researchers have invented a new AI tool which is poised to reshape virtual screening in early-stage drug discovery and enhance scientists’ ability to identify potential new medicines.
The team of scientists behind Australia’s first mRNA COVID-19 vaccine have published a new study demonstrating the vaccine's ability to overcome the issue of ‘immune imprinting.’
Urgent action is needed to design greener drugs that maintain efficacy while minimising environmental impact, according to an international study published in Nature Sustainability and involving Monash University researchers.
Researchers have developed a new method for the detection of neurodegenerative diseases, such as Alzheimer’s, by “lighting up” clusters of misfolded proteins in the brain.
New study has revealed that more than two thirds of clinical practice guidelines do not contain any guidance on deprescribing - the process to reduce the dose of a medication, or work toward stopping.
Victorian Deputy Premier and Minister for Medical Research the Hon Ben Carroll today officially opened the newly built MMIC within the heart of the Monash Technology Precinct, Clayton.
A team of researchers have published the first compelling evidence of the therapeutic potential of a new therapy to treat hypertension-induced organ damage.
See how our Faculty is contributing to the University’s efforts to tackle challenges we face as a global community head on through its research, innovation and education.
Read about Distinguished Alumnus Adjunct Professor Craig Rayner’s journey from his student days at Monash through to his decades-long global career, which has ultimately led to his current role at Moderna.
Return to issue home page.
